BioSpace News Archive

Business

Evotec enters partnership with Kazia Therapeutics for clinical development of EVT801

Evotec SE announced that the Company has entered into both a licensing and master service agreement with Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company.

April 19, 2021
·
5 min read
Drug Development

NeoTX Announces FDA Clearance of IND for Phase 2 Clinical Trial of Naptumomab Estafenatox (NAP), its lead Tumor Targeted Superantigen Candidate

Phase 2a trial in non-small cell lung cancer expected to begin enrollment in the US in the second half of 2021

April 19, 2021
·
2 min read
The largest skin cancer lab in Australia live with Sectra’s digital pathology solution

International medical imaging IT and cybersecurity company Sectra has deployed its software for digital pathology at Southern Sun Pathology, the largest dedicated skin cancer lab in Australia.

April 19, 2021
·
4 min read
Business

Agiomix is selected as the Official Operator for the Egyptian Genome Project

Egypt has announced its plans to establish a map of the Egyptian human genome and enter the world of precision medicine; the Egyptian President Abdel Fattah El Sisi has been briefed on the development of the project by Prime Minister Mustafa Mabdouli and Minister of Higher Education Khaled Abdel Ghaffar.

April 19, 2021
·
1 min read
Business

Ixaka appoints Christian Hoyer Millar as a Non-Executive Director

Ixaka Ltd, an integrated cell and gene therapy company focused on the natural power of the body to cure disease, announces that Christian Hoyer Millar has joined the Company’s Board as a Non-Executive Director.

April 19, 2021
·
3 min read
Drug Development

FDA Gives Go-Ahead for XBiotech’s Candidate Therapy for Phase I/II Double-blind Placebo Controlled Study in Pancreatic CancerXBiotech’s New Drug to Enter Clinical Studies in Combination Therapy for Pancreatic Cancer

XBiotech announced that the FDA has granted permission to commence clinical trials with its novel drug candidate for treating patients with pancreatic cancer.

April 19, 2021
·
6 min read
ERS Genomics and NUVISAN ICB Sign CRISPR/Cas9 License Agreement

ERS Genomics Limited and NUVISAN Innovation Campus Berlin GmbH announced a non-exclusive license agreement granting NUVISAN ICB access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

April 19, 2021
·
2 min read
Lone Star Bio

RETINA-AI Health, Inc. is Awarded U.S. Patent for AI Detection of Eye Disease

RETINA-AI Health Inc. has been awarded a U.S. patent on its Artificial Intelligence systems for autonomous detection of eye diseases from images.

April 19, 2021
·
2 min read
Genetown

Surface Oncology Named a 2021 Best Places to Work Company by Boston Business Journal

Surface Oncology, a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced that it has been recognized by the Boston Business Journal as one of the Best Places to Work in 2021.

April 19, 2021
·
2 min read
Microbix to Present at Bloom Burton Investor ConferenceVirtual Healthcare Investor Conference on April 20 & 21

Microbix Biosystems Inc., a life sciences innovator and exporter, announces that its CEO, Cameron Groome, has been invited to present at the 2021 Bloom Burton & Co. Healthcare Investor Conference, being held virtually from Toronto, Ontario, Canada, on April 20 and 21, 2021.

April 19, 2021
·
4 min read